MK-0731

MK-0731 Uses, Dosage, Side Effects, Food Interaction and all others data.

MK-0731 is a kinesin spindle protein inhibitor and antineoplastic agent.

Trade Name MK-0731
Generic MK-0731
Type
Formula C25H28F3N3O2
Weight Average: 459.5039
Monoisotopic: 459.21336177
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
MK-0731
MK-0731

Innovators Monograph

You find simplified version here MK-0731



https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=11655511
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99444508
https://www.chemspider.com/Chemical-Structure.9830249.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50252149
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL481931
https://zinc.docking.org/substances/ZINC000014209414
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/K30
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide
(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE
3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID
N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine
1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA
ABT-341
4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL
2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide
4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol
4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL
Esophageal culture
Electroretinography
Vitamin B12 level
Thyroid Antibodies
V/Q Scan
Blood pressure measurement
Glucose-6-phosphate dehydrogenase test
Glucose urine test
Zika Virus Test
Lung plethysmography
Treatment-resistant Schizophrenia
Symptomatic Botulism caused by Clostridium botulinum serotype D
Oral phenytoin treatment
Gastro-esophageal Reflux Disease (GERD)
Erythrasma
Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Bone
Non ST Segment Elevation Acute Coronary Syndrome
Recurrent Cervical Cancer
Recurrent Rheumatic fever